XML 77 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
Divestitures (Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 12 Months Ended
Jul. 07, 2016
Dec. 31, 2016
Mar. 31, 2017
Mar. 31, 2016
Mar. 31, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestitures     $ 110,717 $ 0 $ 18,500
North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group | Pediacare, New Skin and Fiber Choice | Disposal group, disposed of by sale, not discontinued operations          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Consideration, excluding costs of inventory $ 40,000        
Proceeds from divestitures 40,100        
Consideration, cost of inventory $ 2,600        
Consideration, holdback term 18 months        
Total purchase price received $ 42,380        
Pre-tax net (gain) on divestitures 54,128        
North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group | Dermoplast | Disposal group, disposed of by sale, not discontinued operations          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Proceeds from divestitures   $ 48,400      
Deposit for agreement to purchase $ 1,250        
North American OTC Healthcare | Cough and Cold, Dermatologicals, and Gastrointestinal products group | E.P.T. and Dermoplast | Disposal group, disposed of by sale, not discontinued operations          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]          
Total purchase price received   59,614      
Pre-tax net (gain) on divestitures   $ (3,589)